Hep Email Update
Hepatitis C and the COVID Vaccine

Should hepatitis C patients consult with a liver specialist prior to receiving the COVID vaccine?

Advertisement
Antiviral Therapy for Hepatitis C Lowers Cardiovascular Disease Risk

The risk was lower in people who had achieved a sustained virological response compared with those who had not.

NVHR Announces New Strategic Objectives to Help Guide the Fight to Eliminate Viral Hepatitis

NVHR will continue to lead efforts to eliminate viral hepatitis by 2030 using new strategic objectives, a refreshed website and a new look.

Self-Care in the COVID-19 Era

People living with chronic illnesses are coming up with ingenious coping mechanisms in the face of COVID-19.

#Coronavirus
Get the latest updates!
2020 Top Hep Treatment Stories

The link between COVID-19 and liver disease, along with research about NAFLD and NASH, topped the list.

Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
1001 6th Ave, Fl 12
New York, NY 10018-5460

Add us to your address book

Copyright (C) 2021 Smart + Strong 1001 6th Ave, Fl 12 New York, NY 10018-5460 USA All rights reserved.
Terms Of Use and Your Privacy.